BSD Medical Signs Exclusive Distribution Agreement with CyberKnife Korea for Distribution of BSD's Hyperthermia Systems in South Korea

BSD Medical Corporation (NASDAQ: BSDM) announced today that the Company has signed an exclusive agreement with CyberKnife Korea (CKK) for the sale and distribution of BSD's hyperthermia products in South Korea. CKK is a premier distributor of sophisticated medical devices in South Korea and represents a number of major medical device companies. CKK is a leading distributor of oncology products in South Korea and has established strong relationships with radiation oncologists throughout the country. As part of the agreement, CKK is required to purchase a minimum number of hyperthermia systems from BSD each year. BSD will initially focus on the regulatory approval for and distribution of the BSD-500 Hyperthermia System and then expand distribution to include the BSD-2000 Hyperthermia System.

South Korea ranks as one of the world's leading economies, with a population of 61 million and overall GDP among the top 15 in the world. As a result, much of the population expects a high level of medical care. The South Korea medical equipment market is focused on high-end, innovative technology with a strong reliance on imported products. The 2010 oncology market in South Korea was approximately US $840 million.